MedPath

Efficacy and Neuroimaging Mechanisms of Smoking Cessation in China

Not Applicable
Completed
Conditions
Cigarette Smoking
Smoking Cessation
Psychological Interventions
Interventions
Behavioral: Cognitive behavior therapy
Registration Number
NCT05788068
Lead Sponsor
Sir Run Run Shaw Hospital
Brief Summary

This proposed project is to assess the efficacy of CBT-based digital smoking cessation interventions in China, as well as explore its neuroimaging mechanisms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. Use cigarettes for no less than 1 year, and use cigarettes ≥ 10 per day
  2. Nicotine dependence (FTCD ≥ 3)
  3. Willing to make an attempt to quit smoking in the next month, and have not quit smoking in the past 3 months, and .
  4. No other addictions except nicotine
  5. Education level of junior high school or above
  6. Age between 18 to 45 years old
  7. Right-handed
  8. No contraindication of MRI scanning
  9. Willing to provide informed consent to participate in the study.
Exclusion Criteria
  1. Patients who are receiving medication
  2. Previous and current mental disorders,and/or mental disorders in line with DSM-5 diagnostic criteria in two departments and three generations.
  3. Brain organic disease, brain injury history, coma history
  4. Serious physical disease, endocrine disease history, abnormal blood picture, heart, liver and kidney function after examination
  5. Pregnant and lactating women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Intervention GroupCognitive behavior therapyParticipants in the intervention group will receive CBT-based digital smoking cessation intervention. The intervention is a set of smoking cessation methods based on the theoretical study of cognitive behavioral therapy for smoking cessation, and its effectiveness has been confirmed through our large sample of randomized controlled studies. This study plans to intervene smokers for 4 weeks after the start of smoking cessation.
Primary Outcome Measures
NameTimeMethod
Biochemically Validated Continuously Abstinence4 weeks

Biochemical validation of 4-week continuous smoking abstinence by urine cotinine test.

Brain Structural Characteristics4 weeks

Differences of brain structure between successful and unsuccessful smokers after intervention, which will be measured by white matter volume, gray matter volume, cortical thickness, and surface area.

Brain Functional activity4 weeks

Differences of whole brain function activity between successful and unsuccessful smokers after intervention, which will be measured by ReHo, ALFF, fALFF, and functional connectivity (FC)

Secondary Outcome Measures
NameTimeMethod
Self-reported 7-day Point Abstinence4 weeks

Self-reported 7-day point-prevalence abstinence at week 1, 4, 8, 12, 16, 20 and 26 after quit date.

Self-reported Continuous Abstinence4 weeks

Self-reported continuous smoking abstinence rate at weeks 4, 8, 12, 16, 20, and 26 after the quit date.

Trial Locations

Locations (1)

Yanhui Liao

🇨🇳

Hanzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath